Literature DB >> 29885987

The Relationship of Current Cognitive Activity to Brain Amyloid Burden and Glucose Metabolism.

Clayton E Lyons1, Dana Tudorascu2, Beth E Snitz3, Julie Price4, Howard Aizenstein1, Oscar Lopez3, Brian Lopresti5, Charles Laymon5, Davneet Minhas5, Ilyas Kamboh6, Chester Mathis5, William Klunk7, Ann D Cohen8.   

Abstract

Several studies have investigated how lifetime cognitive engagement affects levels of amyloid-beta (Aβ) deposition in the brain. However, there has been some disagreement, leaving the relationship of cognitive activity (CA) to Aβ a largely open question. The present study investigated the relationship between CA, Aβ deposition, and glucose metabolism. One hundred nine cognitively normal participants underwent Pittsburgh Compound-B (PiB) and [18F]fluorodeoxyglucose-positron emission tomography and completed a questionnaire designed to measure current CA. Statistical analyses revealed significant differences in PiB retention between those in the high and low CA groups. Linear regression models revealed a significant negative relationship between PiB retention and CA and a significant positive relationship between glucose metabolism and CA. These data suggest that CA may have a direct beneficial effect on the pathophysiology of AD or reflect another underlying process that results in both higher CA and lower AD pathophysiology.
Copyright © 2018 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FDG-PET; aging; lifestyle activities; pittsburgh compound-B

Mesh:

Substances:

Year:  2018        PMID: 29885987      PMCID: PMC6482956          DOI: 10.1016/j.jagp.2018.03.018

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   7.996


  47 in total

1.  Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

Authors:  V L Villemagne; K E Pike; D Darby; P Maruff; G Savage; S Ng; U Ackermann; T F Cowie; J Currie; S G Chan; G Jones; H Tochon-Danguy; G O'Keefe; C L Masters; C C Rowe
Journal:  Neuropsychologia       Date:  2008-02-14       Impact factor: 3.139

2.  Characteristics of the Florida cognitive activities scale in older African Americans.

Authors:  Vonetta M Dotson; John A Schinka; Lisa M Brown; James A Mortimer; Amy R Borenstein
Journal:  Assessment       Date:  2008-03

3.  Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.

Authors:  E C Mormino; J T Kluth; C M Madison; G D Rabinovici; S L Baker; B L Miller; R A Koeppe; C A Mathis; M W Weiner; W J Jagust
Journal:  Brain       Date:  2008-11-28       Impact factor: 13.501

4.  Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.

Authors:  Christopher C Rowe; Kathryn A Ellis; Miroslava Rimajova; Pierrick Bourgeat; Kerryn E Pike; Gareth Jones; Jurgen Fripp; Henri Tochon-Danguy; Laurence Morandeau; Graeme O'Keefe; Roger Price; Parnesh Raniga; Peter Robins; Oscar Acosta; Nat Lenzo; Cassandra Szoeke; Olivier Salvado; Richard Head; Ralph Martins; Colin L Masters; David Ames; Victor L Villemagne
Journal:  Neurobiol Aging       Date:  2010-05-15       Impact factor: 4.673

5.  Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease.

Authors:  Scott K Ziolko; Lisa A Weissfeld; William E Klunk; Chester A Mathis; Jessica A Hoge; Brian J Lopresti; Steven T DeKosky; Julie C Price
Journal:  Neuroimage       Date:  2006-08-14       Impact factor: 6.556

Review 6.  PET imaging in the assessment of normal and impaired cognitive function.

Authors:  Daniel H S Silverman; Abass Alavi
Journal:  Radiol Clin North Am       Date:  2005-01       Impact factor: 2.303

7.  Cross-validation of the Florida Cognitive Activities Scale (FCAS) in an Alzheimer's disease research center sample.

Authors:  John A Schinka; Ashok Raj; David A Loewenstein; Brent J Small; Ranjan Duara; Huntington Potter
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-08-24       Impact factor: 2.680

8.  Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Authors:  Kerryn E Pike; Greg Savage; Victor L Villemagne; Steven Ng; Simon A Moss; Paul Maruff; Chester A Mathis; William E Klunk; Colin L Masters; Christopher C Rowe
Journal:  Brain       Date:  2007-10-10       Impact factor: 13.501

9.  Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease.

Authors:  Nina M Kemppainen; Sargo Aalto; Mira Karrasch; Kjell Någren; Nina Savisto; Vesa Oikonen; Matti Viitanen; Riitta Parkkola; Juha O Rinne
Journal:  Ann Neurol       Date:  2008-01       Impact factor: 10.422

10.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

Authors:  E M Reiman; R J Caselli; L S Yun; K Chen; D Bandy; S Minoshima; S N Thibodeau; D Osborne
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

View more
  1 in total

Review 1.  How Do Cognitively Stimulating Activities Affect Cognition and the Brain Throughout Life?

Authors:  Mara Mather
Journal:  Psychol Sci Public Interest       Date:  2020-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.